241 related articles for article (PubMed ID: 33982796)
41. Non-Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation: Changing Clinical Practice and Outcomes for Stroke Prevention in a Nationwide Cohort Study.
Cheng WH; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA; Chao TF
Mayo Clin Proc; 2021 Jan; 96(1):52-65. PubMed ID: 33413835
[TBL] [Abstract][Full Text] [Related]
42. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
[TBL] [Abstract][Full Text] [Related]
43. Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: Experience from the real world.
Alnsasra H; Haim M; Senderey AB; Reges O; Leventer-Roberts M; Arnson Y; Leibowitz M; Hoshen M; Avgil-Tsadok M
Heart Rhythm; 2019 Jan; 16(1):31-37. PubMed ID: 30125717
[TBL] [Abstract][Full Text] [Related]
44. Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation.
Durham TA; Hassmiller Lich K; Viera AJ; Fine JP; Mukherjee J; Weinberger M; Dusetzina SB
Am J Cardiol; 2017 Nov; 120(10):1820-1829. PubMed ID: 28867127
[TBL] [Abstract][Full Text] [Related]
45. Uptake in antithrombotic treatment and its association with stroke incidence in atrial fibrillation: insights from a large German claims database.
Hohnloser SH; Basic E; Nabauer M
Clin Res Cardiol; 2019 Sep; 108(9):1042-1052. PubMed ID: 30771066
[TBL] [Abstract][Full Text] [Related]
46. Temporal trends of gender disparities in oral anticoagulant use in patients with atrial fibrillation.
Teppo K; Airaksinen KEJ; Jaakkola J; Halminen O; Salmela B; Kalatsova K; Kouki E; Haukka J; Putaala J; Linna M; Aro AL; Mustonen P; Hartikainen J; Lehto M
Eur J Clin Invest; 2024 Jan; 54(1):e14107. PubMed ID: 37823410
[TBL] [Abstract][Full Text] [Related]
47. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
[TBL] [Abstract][Full Text] [Related]
48. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
49. Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016.
Maura G; Billionnet C; Drouin J; Weill A; Neumann A; Pariente A
BMJ Open; 2019 Apr; 9(4):e026645. PubMed ID: 31005934
[TBL] [Abstract][Full Text] [Related]
50. Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Clin Res Cardiol; 2022 Jan; 111(1):23-33. PubMed ID: 33704551
[TBL] [Abstract][Full Text] [Related]
51. It can be safe to discontinue oral anticoagulants after successful atrial fibrillation ablation: A systematic review and meta-analysis of cohort studies.
Wang X; Li M; Wang X; Zhang Z
Medicine (Baltimore); 2023 Oct; 102(42):e35518. PubMed ID: 37861532
[TBL] [Abstract][Full Text] [Related]
52. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services.
Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I
Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863
[TBL] [Abstract][Full Text] [Related]
53. Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.
Ramakumar V; Benz AP; Karthikeyan G
Indian Heart J; 2021; 73(2):244-248. PubMed ID: 33865530
[TBL] [Abstract][Full Text] [Related]
54. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
Højen AA; Nielsen PB; Riahi S; Jensen M; Lip GYH; Larsen TB; Søgaard M
Br J Clin Pharmacol; 2022 Aug; 88(8):3847-3855. PubMed ID: 35355307
[TBL] [Abstract][Full Text] [Related]
55. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
56. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
Shiyovich A; Shalev V; Chodick G; Tirosh M; Katz A; Klar MM; Shuvy M; Pereg D; Minha S
BMC Cardiovasc Disord; 2021 Oct; 21(1):493. PubMed ID: 34645389
[TBL] [Abstract][Full Text] [Related]
57. Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort study.
Atterman A; Friberg L; Asplund K; Engdahl J
Europace; 2020 Jan; 22(1):58-65. PubMed ID: 31750897
[TBL] [Abstract][Full Text] [Related]
58. Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
Munir MB; Hlavacek P; Keshishian A; Guo JD; Mallampati R; Ferri M; Russ C; Emir B; Cato M; Yuce H; Hsu JC
PLoS One; 2022; 17(2):e0263903. PubMed ID: 35176074
[TBL] [Abstract][Full Text] [Related]
59. A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants.
Claxton JS; MacLehose RF; Lutsey PL; Norby FL; Chen LY; O'Neal WT; Chamberlain AM; Bengtson LGS; Alonso A
Heart Rhythm; 2019 Jun; 16(6):820-826. PubMed ID: 30550837
[TBL] [Abstract][Full Text] [Related]
60. Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation.
Pothineni NVK; Amankwah N; Santangeli P; Schaller RD; Supple GE; Deo R; Nazarian S; Garcia FC; Dixit S; Callans DJ; Marchlinski FE; Frankel DS
J Cardiovasc Electrophysiol; 2021 Feb; 32(2):345-353. PubMed ID: 33382500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
